Technology

ChronoScale Rockets 18% on Tesla Vet's Appointment as CTO

ChronoScale shares jumped 17.8% to $22.43 after naming former Tesla VP Raj Jegannathan as CTO and Lawrence Lam as CPO, signaling a push to scale its AI infrastructure business.

Sarah Chen · · 3 min read · 1 views
ChronoScale Rockets 18% on Tesla Vet's Appointment as CTO
Mentioned in this article
APLD $44.15 -1.25% EKSO $19.04 -0.52%

ChronoScale Corporation (CHRN) saw its stock price surge nearly 18% on Thursday, reaching $22.43, after the company announced two high-profile executive appointments. The AI compute infrastructure firm named Raj Jegannathan, a former Tesla vice president, as its new chief technology officer, and Lawrence Lam as chief product officer. The appointments come just one month after ChronoScale began trading on the Nasdaq following a complex merger.

The market responded enthusiastically to the news, with shares climbing $3.39 on the day and trading between $18.00 and $22.94. Volume reached approximately 429,000 shares, reflecting strong investor interest in the company's strategic direction.

Jegannathan brings over 13 years of experience from Tesla, where he most recently served as a vice president under Elon Musk. At Tesla, he led teams focused on AI infrastructure, GPU clusters, storage, security, and enterprise technology. His expertise is expected to be pivotal in advancing ChronoScale's accelerated compute infrastructure, which includes data-center hardware designed for training and running artificial intelligence models.

Lawrence Lam, the newly appointed CPO, adds over two decades of cloud and AI platform experience. ChronoScale noted that Lam has managed more than $20 billion in AI infrastructure deployments, underscoring his capability to drive product strategy in a highly competitive market. A GPU, or graphics processing unit, is a critical component in AI workloads.

ChronoScale CEO Cenly Chen emphasized the importance of the new hires, stating that their experience is crucial in an industry where “performance, efficiency, and execution matter.” Jegannathan highlighted the growing pressure on firms to demonstrate that AI investments yield “real-world outcomes,” while Lam noted that customers increasingly demand integrated systems encompassing compute, networking, storage, and operations.

The company's stock structure remains a key factor for investors. According to SEC filings, ChronoScale closed on May 5 with 143.1 million shares outstanding, of which Applied Digital Corp and its affiliates owned approximately 97%. Based on the $22.43 price, the company's equity value is roughly $3.21 billion, with legacy stockholders retaining only about 3% after the deal closed.

ChronoScale was formed through the merger of Applied Digital's cloud unit with Ekso Bionics Holdings. Nasdaq confirmed that EKSO switched to the CHRN ticker as of May 5, now representing ChronoScale Corporation. The company sells accelerated compute infrastructure, including data-center hardware for AI model training and inference.

AI infrastructure stocks showed mixed performance on Thursday. Applied Digital slipped 0.6%, while CoreWeave dropped 1.4% and Nebius gained 3.5%. Broader market sentiment was mixed, with Wall Street rising but chip stocks dragging on the Nasdaq after Broadcom's results. Oliver Pursche of Wealthspire Advisors noted that “the right companies are being rewarded” in AI stocks, while laggards face punishment.

Despite the sharp rally, analysts caution that execution risks remain significant. ChronoScale's filings and public statements cite potential delays in integration following the merger, challenges in achieving expected benefits, and questions about retaining top talent. The company also lists customer concentration, cash flow, and capital access as key risk factors. If AI compute demand softens or if new management fails to convert technical expertise into signed capacity and steady revenue, the stock's recent gains could prove vulnerable.

This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Market data may be delayed. Always conduct your own research and consult a licensed financial advisor before making investment decisions.

Related Articles

View All →